Xalkori Capsule, Coated Pellets
Product Images NDC 0069-0251

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Xalkori (NDC 0069-0251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xalkori 01)

Chemical structure of crizotinib, the active ingredient in Xalkori. The structure shows a complex arrangement of rings and atoms including chlorine, fluorine, nitrogen, oxygen, and methyl groups as part of the molecule.*

FDA Label Image

Figure 1 (Xalkori 02)

A Kaplan-Meier progression-free survival probability graph comparing Xalkori (crizotinib) to chemotherapy over time in months. The curve shows higher survival probability for Xalkori patients (median 10.9 months) versus chemotherapy patients (median 7.0 months). The chart includes a hazard ratio of 0.45 with 95% confidence interval and a risk table below showing patient numbers at risk over time for both groups.*

FDA Label Image

Figure 2 (Xalkori 03)

A Kaplan-Meier survival curve chart showing progression-free survival probability (%) over time (months) comparing Xalkori (crizotinib) and chemotherapy. The plot includes median survival times, hazard ratio, confidence interval, and p-value, with number at risk table below for both treatment groups.*

FDA Label Image

Logo (Xalkori 04)

FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

Xalkori 250 mg capsules coated pellets label by Pfizer Laboratories Division of Pfizer Inc. The label shows the drug name with generic name crizotinib, dosage strength of 250 mg, and package size containing 60 capsules. Storage instructions indicate room temperature 20° to 25°C with permitted excursions, and dispensing requirements note tight containers and enclosed medication guide. Origin is Made in Ireland.*

FDA Label Image

Xalkori 07

Xalkori 200 mg capsules containing crizotinib, oral coated pellets in a bottle of 60 capsules. The label states to swallow capsules whole and indicates prescription use only. Manufactured by Pfizer Laboratories Division, Pfizer Inc. The label includes storage instructions, a barcode, and batch information areas.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.